Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Merck KGaA's other current liabilities for the quarter that ended in Mar. 2026 was MXN91,685 Mil.
Merck KGaA's quarterly other current liabilities
increased
from Sep. 2025 (MXN73,549 Mil) to Dec. 2025 (MXN81,468 Mil) and
increased
from Dec. 2025 (MXN81,468 Mil) to Mar. 2026 (MXN91,685 Mil).
Merck KGaA's annual other current liabilities
increased
from Dec. 2023 (MXN72,728 Mil) to Dec. 2024 (MXN88,686 Mil) but then
declined
from Dec. 2024 (MXN88,686 Mil) to Dec. 2025 (MXN81,468 Mil).
Merck KGaA Other Current Liabilities Related Terms
Merck KGaA Other Current Liabilities Historical Data
* Premium members only.
The historical data trend for Merck KGaA's Other Current Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
What does a Other Current Liabilities of MXN91,685 Mil mean?
Merck KGaA (MEX:MRK1N) has a Other Current Liabilities of MXN91,685 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Merck KGaA.
Is Merck KGaA's Other Current Liabilities too high?
Merck KGaA's current Other Current Liabilities is MXN91,685 Mil. Overall, Merck KGaA has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Merck KGaA's Other Current Liabilities compare to ZTS and UTHR?
Merck KGaA's Other Current Liabilities of MXN91,685 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Merck KGaA. Merck KGaA's current Other Current Liabilities is MXN91,685 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck KGaA stock overvalued right now?
Merck KGaA (MEX:MRK1N) has a current Other Current Liabilities of MXN91,685 Mil. The stock's GF Value™ is MXN3,360.43, compared to a current price of MXN3,299.85 — trading 1.8% below its estimated fair value. The current Other Current Liabilities is MXN91,685 Mil. Merck KGaA's overall GF Score™ is 88/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Merck KGaA (MEX:MRK1N), the current Other Current Liabilities is MXN91,685 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merck KGaA (MEX:MRK1N) Overvalued in 2026?
Based on GuruFocus' analysis, Merck KGaA stock appears to be undervalued.
The current stock price of MXN3,299.85 is trading 1.8% below its estimated GF Value™ of MXN3,360.43.
Key valuation signals for MEX:MRK1N:
Other Current Liabilities: MXN91,685 Mil
GF Value™: MXN3,360.43 vs. price of MXN3,299.85 (1.8% below fair value)
No single metric tells the full story. See the MEX:MRK1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
88GF Score
Get the complete analysis for MEX:MRK1N
Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MRK1N has been successfully added to your 
